Fundraising FoxSEngine Precision Medicine
Seattle, US · Founded 2015 · Delaware corporation · 4 known investors
Find your way into SEngine Precision Medicine
Sign up to see every warm intro you have to SEngine Precision Medicine
- Paths you didn't know you had: your email and LinkedIn already hold routes to the SEngine Precision Medicine team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
SEngine Precision Medicine was founded in 2015 by Christopher Kemp and Carla Grandori.
CK
Christopher KempCo-founder
CG
Carla GrandoriCo-founder · Chief Executive Officer2015–2023She brings over 30 years of cancer research experience, including roles as VP of clinical modeling and functional genomics at Tempus AI and research positions at Fred Hutchinson Cancer Research Center and the University of Washington.
EB
Elliott BurklandNamed on SEC filing
TN
LH
Lee HartwellNamed on SEC filing
JF
Jesse FerrerNamed on SEC filing
UM
Ulrich MuellerNamed on SEC filing
Investors · 4
ALETHEA FULCRUMreportedRancho Santa Fe
How we know: funding news · biospace.com · Not right? Tell us
Also in the syndicate · 3
Bangarang GroupVincere Capital Biotech LLCWashington Research Foundationlead
Funding
SEC filings, press & company announcements$14.3M disclosed across 3 of 4 rounds · 2018–2023
- Undisclosed amountSeries A2Jul 2022
Washington Research Foundation (lead), Alethea Fulcrum Fund, Bangarang Group, Vincere Capital Biotech LLC
Source ↗ - $5.1MSeries AOct 2019 · 2 sourcesSource ↗
▶$600KraisedMar 2023 · 2 investors · BiotechnologyRule 506(b)
▶$600KraisedMar 2023 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Christopher KempExecutive Officer, Promoter
- Pablo PrichardDirector
- Tony HsuExecutive Officer
- Elliott BurklandDirector
- Carla GrandoriExecutive Officer, Director, Promoter
- Offering amount
- $3.6M
- Amount sold
- $600K
- First sale
- Feb 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$8.6MraisedOct 2019 · 40 investors · BiotechnologyRule 506(b)
▶$8.6MraisedOct 2019 · 40 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Elliott BurklandDirector
- Tom NearyExecutive Officer
- Christopher KempExecutive Officer, Promoter
- Lee HartwellDirector
- Jesse FerrerDirector
- Ulrich MuellerExecutive Officer
- Carla GrandoriExecutive Officer, Director, Promoter
- Offering amount
- $13.6M
- Amount sold
- $8.6M
- First sale
- Aug 2018
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who founded SEngine Precision Medicine?
- SEngine Precision Medicine was founded by Christopher Kemp, Carla Grandori in 2015.
- Who are SEngine Precision Medicine's investors?
- SEngine Precision Medicine's investors include ALETHEA FULCRUM.
- How much funding has SEngine Precision Medicine raised?
- SEngine Precision Medicine has disclosed $14.3M raised across 3 of its 4 known rounds.
- Where is SEngine Precision Medicine headquartered?
- SEngine Precision Medicine is headquartered in Seattle, US.